CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2021
Detailed information
CancerLivER ID2021
BiomarkercircFUT8
Biomarker Name/Symbol (given in Publication)circFUT8
BiomoleculecircRNAs
SubjectHuman
Degree of ValidityNovel biomarkers and therapeutic targets for HCC and validated on independent dataset
Experimental ConditionLiver cancer v/s Normal
Cancer typeHepatocellular carcinoma
RegulationUpregulated in liver cancer (with fold change 11.44)
Level of significance p < 0.01
SourceTissue
PMID28727484
Type of BiomarkerDiagnostic
Pathwayp53 signaling pathway and pathways involved in angiogenesis and cell cycle.
CohortTraining dataset contain 30 pairs tissues (cancer and adjacent normal) are recruited from China-Japan Union hospital of Jilin University and validation dataset contain 40 paired clinical samples of liver cancer tissues and their paired adjacent normal liver tissues
SensitivityNA
SpecificityNA
AccuracyNA
AUC0.76
DiseaseHuman liver cancer
Year of Publication2017
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top